Follow
Mohammad Javad Fattahi
Mohammad Javad Fattahi
Assistant professor of medical immunology, Shiraz University of Medical Sciences, Shiraz, Iran
Verified email at sums.ac.ir
Title
Cited by
Cited by
Year
Prostaglandins and rheumatoid arthritis
MJ Fattahi, A Mirshafiey
Arthritis 2012, 2012
1302012
CTLA‐4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers
A Hadinia, SV Hossieni, N Erfani, M Saberi‐Firozi, MJ Fattahi, A Ghaderi
Journal of gastroenterology and hepatology 22 (12), 2283-2287, 2007
912007
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women
B Khadang, MJ Fattahi, A Talei, AS Dehaghani, A Ghaderi
Cancer genetics and cytogenetics 173 (1), 38-42, 2007
752007
CSF levels of cytokines in neuro-Behçet's disease
AB Haghighi, H Ittehadi, AR Nikseresht, J Rahmati, SG Poorjahromi, ...
Clinical neurology and neurosurgery 111 (6), 507-510, 2009
712009
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug
MJ Fattahi, M Abdollahi, A Agha Mohammadi, N Rastkari, R Khorasani, ...
Immunopharmacology and immunotoxicology 37 (6), 535-540, 2015
672015
Targeting of crosstalk between tumor and tumor microenvironment by β‐D mannuronic acid (M2000) in murine breast cancer model
F Hosseini, H Hassannia, A Mahdian‐Shakib, F Jadidi‐Niaragh, ...
Cancer medicine 6 (3), 640-650, 2017
482017
p53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients
Z Mojtahedi, MR Haghshenas, SV Hosseini, MJ Fattahi, A Ghaderi
Indian journal of cancer 47 (1), 31-34, 2010
392010
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: a 12-week randomized, placebo-controlled, phase I/II clinical trial
MJ Fattahi, AR Jamshidi, M Mahmoudi, M Vojdanian, MS Yekaninejad, ...
International immunopharmacology 54, 112-117, 2018
372018
Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression
Z Mojtahedi, B Khademi, SB Hashemi, SMB Abtahi, MA Ghasemi, ...
Pathology & Oncology Research 17, 7-10, 2011
372011
Interleukin-18 gene promoter and serum level in women with ovarian cancer
A Samsami Dehaghani, K Shahriary, MA Kashef, S Naeimi, MJ Fattahi, ...
Molecular biology reports 36, 2393-2397, 2009
372009
HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated
Y Sardari, S Pardis, AA Tadbir, MJ Ashraf, MJ Fattahi, H Ebrahimi, ...
Asian Pacific Journal of Cancer Prevention 13 (6), 2891-2896, 2012
332012
Positive and negative effects of prostaglandins in A lzheimer's disease
MJ Fattahi, A Mirshafiey
Psychiatry and Clinical Neurosciences 68 (1), 50-60, 2014
312014
Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma
M Hamzavi, AA Tadbir, G Rezvani, MJ Ashraf, MJ Fattahi, B Khademi, ...
Asian Pacific Journal of Cancer Prevention 14 (3), 1681-1685, 2013
312013
Analysis of BRCA1 and BRCA2 mutations in southern Iranian breast cancer patients
MJ FATAHI, Z Mojtahedi, AN KARIM, ABDA TALEEI, SJ Banani, ...
ARCHIVES OF IRANIAN MEDICINE 12 (6), 584-587, 2009
302009
Serum level of vascular endothelial growth factor in patients with different clinical subtypes of oral lichen planus
M Mardani, J Ghabanchi, MJ Fattahi, AA Tadbir
Iranian Journal of Medical Sciences 37 (4), 233, 2012
292012
The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients
M Roozbehkia, M Mahmoudi, S Aletaha, N Rezaei, MJ Fattahi, ...
International immunopharmacology 52, 191-196, 2017
282017
Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern iran
SB Mahjour, F Ghaffarpasand, MJ Fattahi, A Ghaderi, A Fotouhi Ghiam, ...
Pathology & Oncology Research 16, 579-582, 2010
282010
Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property
S Nazeri, S Khadem Azarian, MJ Fattahi, R Sedaghat, F Tofighi Zavareh, ...
Immunopharmacology and Immunotoxicology 39 (2), 59-65, 2017
262017
Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis
MJ Fattahi, H Ahmadi, F Jafarnezhad-Ansariha, SS Mortazavi-Jahromi, ...
Biomedicine & Pharmacotherapy 100, 495-500, 2018
232018
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-d-mannuronic acid in rheumatoid arthritis patients
H Ahmadi, AR Jamshidi, F Gharibdoost, M Mahmoudi, N Rastkari, ...
Inflammopharmacology 26, 737-745, 2018
202018
The system can't perform the operation now. Try again later.
Articles 1–20